71 related articles for article (PubMed ID: 38669609)
21. Cutaneous melanoma: available therapy for metastatic disease.
Tarhini AA; Agarwala SS
Dermatol Ther; 2006; 19(1):19-25. PubMed ID: 16405566
[TBL] [Abstract][Full Text] [Related]
22. Systematic review of medical treatment in melanoma: current status and future prospects.
Garbe C; Eigentler TK; Keilholz U; Hauschild A; Kirkwood JM
Oncologist; 2011; 16(1):5-24. PubMed ID: 21212434
[TBL] [Abstract][Full Text] [Related]
23. [Melanoma update].
Longvert C; Saiag P
Rev Med Interne; 2019 Mar; 40(3):178-183. PubMed ID: 30527396
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant therapy for resected stage III melanoma patients: high-dose interferon-alpha versus ipilimumab combined with kinases inhibitors.
Minutilli E; Feliciani C
Tumori; 2012; 98(2):185-90. PubMed ID: 22677983
[TBL] [Abstract][Full Text] [Related]
25. Latest advances in chemotherapeutic, targeted, and immune approaches in the treatment of metastatic melanoma.
Shah DJ; Dronca RS
Mayo Clin Proc; 2014 Apr; 89(4):504-19. PubMed ID: 24684873
[TBL] [Abstract][Full Text] [Related]
26. Considering adjuvant therapy for stage II melanoma.
Poklepovic AS; Luke JJ
Cancer; 2020 Mar; 126(6):1166-1174. PubMed ID: 31869447
[TBL] [Abstract][Full Text] [Related]
27. Medical management of melanoma.
Brown CK; Kirkwood JM
Surg Clin North Am; 2003 Apr; 83(2):283-322, viii. PubMed ID: 12744611
[TBL] [Abstract][Full Text] [Related]
28. Metastasectomy for stage IV melanoma.
Deutsch GB; Kirchoff DD; Faries MB
Surg Oncol Clin N Am; 2015 Apr; 24(2):279-98. PubMed ID: 25769712
[TBL] [Abstract][Full Text] [Related]
29. [Melanoma, from diagnosis to treatment].
Baroudjian B; Pagès C; Lebbé C
Rev Infirm; 2016 Mar; (219):16-8. PubMed ID: 26944639
[TBL] [Abstract][Full Text] [Related]
30. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment.
Markovic SN; Erickson LA; Rao RD; Weenig RH; Pockaj BA; Bardia A; Vachon CM; Schild SE; McWilliams RR; Hand JL; Laman SD; Kottschade LA; Maples WJ; Pittelkow MR; Pulido JS; Cameron JD; Creagan ET;
Mayo Clin Proc; 2007 Apr; 82(4):490-513. PubMed ID: 17418079
[TBL] [Abstract][Full Text] [Related]
31. Progression of cutaneous melanoma: implications for treatment.
Leong SP; Mihm MC; Murphy GF; Hoon DS; Kashani-Sabet M; Agarwala SS; Zager JS; Hauschild A; Sondak VK; Guild V; Kirkwood JM
Clin Exp Metastasis; 2012 Oct; 29(7):775-96. PubMed ID: 22892755
[TBL] [Abstract][Full Text] [Related]
32. Successes and limitations of targeted cancer therapy in melanoma.
Romano E; Michielin O
Prog Tumor Res; 2014; 41():78-88. PubMed ID: 24727988
[TBL] [Abstract][Full Text] [Related]
33. Improving patient outcomes to targeted therapies in melanoma.
Eroglu Z; Smalley KS; Sondak VK
Expert Rev Anticancer Ther; 2016 Jun; 16(6):633-41. PubMed ID: 27137746
[TBL] [Abstract][Full Text] [Related]
34. Who benefits most from adjuvant interferon treatment for melanoma?
Gogas H; Abali H; Ascierto PA; Demidov L; Pehamberger H; Robert C; Schachter J; Eggermont AM; Hauschild A; Espinosa E
Am J Ther; 2015; 22(1):54-60. PubMed ID: 24176884
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous Melanoma - A Review of Systemic Therapies.
Lee KA; Nathan P
Acta Derm Venereol; 2020 Jun; 100(11):adv00141. PubMed ID: 32346745
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
37. Novel therapies in melanoma.
Scheier B; Amaria R; Lewis K; Gonzalez R
Immunotherapy; 2011 Dec; 3(12):1461-9. PubMed ID: 22091682
[TBL] [Abstract][Full Text] [Related]
38. Melanoma. A multidisciplinary approach for the general surgeon.
Reeves ME; Coit DG
Surg Clin North Am; 2000 Apr; 80(2):581-601. PubMed ID: 10836008
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline.
Garbe C; Peris K; Hauschild A; Saiag P; Middleton M; Spatz A; Grob JJ; Malvehy J; Newton-Bishop J; Stratigos A; Pehamberger H; Eggermont A
Eur J Cancer; 2010 Jan; 46(2):270-83. PubMed ID: 19959353
[TBL] [Abstract][Full Text] [Related]
40. The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma.
Kim A; Cohen MS
Expert Opin Drug Discov; 2016 Sep; 11(9):907-16. PubMed ID: 27327499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
